Cell Source, Inc. Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
Cell Source, Inc. (CLCS) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) of -$85.67 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease · last filed 2019-08-14
- Cell Source, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2019-06-30 was -$32.83K.
- Cell Source, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2019-03-31 was -$52.84K.
- Cell Source, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-09-30 was -$115.45K.
- Cell Source, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-06-30 was -$139.46K.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 3 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 6 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2019-06-30 | -$32.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$85.67K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$52.84K 10-Q · filed 2019-05-20 | ||
| 2018-09-30 | -$115.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$254.91K derived: sum of 2 quarters · filed 2018-11-14 | -$390.22K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$139.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-18 | -$274.77K 10-Q · filed 2018-10-18 | |
| 2018-03-31 | -$135.32K 10-Q · filed 2018-10-18 | ||
| 2017-09-30 | -$149.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-25 | -$326.69K derived: sum of 2 quarters · filed 2018-07-25 | -$452.87K 10-Q · filed 2018-07-25 |
| 2017-06-30 | -$177.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | -$303.58K 10-Q · filed 2018-07-25 | |
| 2017-03-31 | -$126.18K 10-Q · filed 2018-07-25 | ||
| 2016-09-30 | -$324.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-18 | -$535.32K derived: sum of 2 quarters · filed 2016-11-18 | -$696.27K 10-Q · filed 2016-11-18 |
| 2016-06-30 | -$210.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$371.52K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$160.95K 10-Q · filed 2016-05-13 | ||
| 2015-09-30 | -$16.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$119.10K derived: sum of 2 quarters · filed 2015-11-16 | -$162.50K 10-Q · filed 2015-11-16 |
| 2015-06-30 | -$102.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$146.10K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | -$43.40K 10-Q · filed 2015-05-13 |